Selective Anti-Cancer Effects of Plasma-Activated Medium and Its High Efficacy with Cisplatin on Hepatocellular Carcinoma with Cancer Stem Cell Characteristics

Plasma-activated medium promotes autophagic cell death along with alteration of the mTOR pathway

(2020) Nobuhisa Yoshikawa et al.   Scientific Reports

A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer

(2020) Richard Kim et al.   ONCOLOGIST

Non-thermal atmospheric pressure plasma is an excellent tool to activate proliferation in various mesoderm-derived human adult stem cells

(2019) Jeongyeon Park et al.   FREE RADICAL BIOLOGY AND MEDICINE

Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma

(2019) Ghassan K. Abou-Alfa et al.   JAMA Oncology

Non-thermal atmospheric pressure plasma induces epigenetic modifications that activate the expression of various cytokines and growth factors in human mesoderm-derived stem cells

(2019) Jeongyeon Park et al.   FREE RADICAL BIOLOGY AND MEDICINE

Apoptosis: A Target for Anticancer Therapy

(2018) et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Comparative study of the Ar and He atmospheric pressure plasmas on E-cadherin protein regulation for plasma-mediated transdermal drug delivery

(2018) Hyun Young Lee et al.   JOURNAL OF PHYSICS D-APPLIED PHYSICS

Biological and medical applications of plasma-activated media, water and solutions

(2018) Nagendra Kumar Kaushik et al.   BIOLOGICAL CHEMISTRY

Ten years of sorafenib in hepatocellular carcinoma: Are there any predictive and/or prognostic markers?

(2018) Giorgia Marisi et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Cancer stem cells (CSCs) in cancer progression and therapy

(2018) Masoud Najafi et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16

(2018) Sanjeev Kumar Sagwal et al.   Cell Death & Disease

Sorafenib: A Review in Hepatocellular Carcinoma

(2017) Gillian M. Keating   Targeted Oncology

The role of autophagy in hepatocellular carcinoma: friend or foe

(2017) Lian Liu et al.   Oncotarget

Selective effects of non-thermal atmospheric plasma on triple-negative breast normal and carcinoma cells through different cell signaling pathways

(2017) Yuan Liu et al.   Scientific Reports

Cell survival of glioblastoma grown in medium containing hydrogen peroxide and/or nitrite, or in plasma-activated medium

(2016) Naoyuki Kurake et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide

(2016) Gillian E Conway et al.   BRITISH JOURNAL OF CANCER

Necroptosis in development, inflammation and disease

(2016) Ricardo Weinlich et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

The role of pluripotency factors to drive stemness in gastrointestinal cancer

(2016) Martin Müller et al.   Stem Cell Research

Non-Thermal Atmospheric Pressure Plasma Efficiently Promotes the Proliferation of Adipose Tissue-Derived Stem Cells by Activating NO-Response Pathways

(2016) Jeongyeon Park et al.   Scientific Reports

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics

(2015) Gi-Bang Koo et al.   CELL RESEARCH

Molecular Mechanism and Prediction of Sorafenib Chemoresistance in Human Hepatocellular Carcinoma

(2015) Naoshi Nishida et al.   DIGESTIVE DISEASES

Plasma-activated medium induces A549 cell injury via a spiral apoptotic cascade involving the mitochondrial–nuclear network

(2015) Tetsuo Adachi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Plasma-activated medium suppresses choroidal neovascularization in mice: a new therapeutic concept for age-related macular degeneration

(2015) Fuxiang Ye et al.   Scientific Reports

Effectiveness of plasma treatment on gastric cancer cells

(2014) Koji Torii et al.   Gastric Cancer

Cancer Epigenetics: Tumor Heterogeneity, Plasticity of Stem-like States, and Drug Resistance

(2014) Hariharan Easwaran et al.   MOLECULAR CELL

Nonthermal plasma induces head and neck cancer cell death: the potential involvement of mitogen-activated protein kinase-dependent mitochondrial reactive oxygen species

(2014) S U Kang et al.   Cell Death & Disease

Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance

(2013) Agnieszka Kaczmarek et al.   IMMUNITY

Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating Slug

(2013) Chun Sun et al.   MEDICAL ONCOLOGY

Selective killing of ovarian cancer cells through induction of apoptosis by nonequilibrium atmospheric pressure plasma

(2012) Sachiko Iseki et al.   APPLIED PHYSICS LETTERS

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

(2012) S Hagiwara et al.   BRITISH JOURNAL OF CANCER

Preferential induction of apoptotic cell death in melanoma cells as compared with normal keratinocytes using a non-thermal plasma torch

(2012) Shoshanna N. Zucker et al.   CANCER BIOLOGY & THERAPY

Cancer Stem Cells: Current Status and Evolving Complexities

(2012) Jane E. Visvader et al.   Cell Stem Cell

Combinatorial drug therapy for cancer in the post-genomic era

(2012) Bissan Al-Lazikani et al.   NATURE BIOTECHNOLOGY

Effects of a Non Thermal Plasma Treatment Alone or in Combination with Gemcitabine in a MIA PaCa2-luc Orthotopic Pancreatic Carcinoma Model

(2012) Laura Brullé et al.   PLoS One

CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation

(2011) Terence Kin Wah Lee et al.   Cell Stem Cell

Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib - the role of extracellular signal-regulated kinase counteraction

(2011) Irena Manov et al.   FEBS Journal

ROS implication in a new antitumor strategy based on non-thermal plasma

(2011) Marc Vandamme et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Y-Box Binding Protein-1 Induces the Expression ofCD44andCD49fLeading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance

(2010) Karen To et al.   CANCER RESEARCH

Tumoral and Normal Cells Treatment With High-Voltage Pulsed Cold Atmospheric Plasma Jets

(2010) N Georgescu et al.   IEEE TRANSACTIONS ON PLASMA SCIENCE

Polymer-Caged Nanobins for Synergistic Cisplatin−Doxorubicin Combination Chemotherapy

(2010) Sang-Min Lee et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1

(2010) Te Liu et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Doxorubicin pathways

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

Risk of HCC: Genetic heterogeneity and complex genetics

(2009) Tommaso A. Dragani   JOURNAL OF HEPATOLOGY

Cancer Stem Cells Contribute to Cisplatin Resistance in Brca1/p53-Mediated Mouse Mammary Tumors

(2008) N. Shafee et al.   CANCER RESEARCH

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

(2008) Taro Yamashita et al.   GASTROENTEROLOGY

Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations

(2008) S. Ma et al.   MOLECULAR CANCER RESEARCH